World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
16550
World Ranking
3585
National Ranking
143

Overview

Giuseppe Tambussi is affiliated with Vita-Salute San Raffaele University in Italy and focuses their research primarily in the fields of Medicine and Immunology and Microbiology. Their work encompasses several subfields including Infectious Diseases, Virology, Epidemiology, Applied Microbiology and Biotechnology, and Neurology.

The scientist's research topics cover a range of areas related to infectious conditions and treatments, with particular attention to HIV and COVID-19. Key topics include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • COVID-19 Clinical Research Studies
  • Sepsis Diagnosis and Treatment
  • Antibiotic Use and Resistance
  • Long-Term Effects of COVID-19

Tambussi has contributed to various peer-reviewed journals, with frequent publications appearing in venues such as:

  • Scientific Reports
  • Journal of Virus Eradication
  • Clinical Microbiology and Infection
  • Pathogens and Immunity
  • Annals of Internal Medicine

Notable recent papers include:

  • "Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors" (2020, Clinical Microbiology and Infection)
  • "Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19" (2020, Scientific Reports)
  • "Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study" (2020, Pathogens and Immunity)
  • "Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection" (2020, Annals of Internal Medicine)
  • "Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort" (2020, HIV Medicine)

Collaborations are an important aspect of Tambussi's research output. Frequent coauthors include Silvia Nozza, Marco Ripa, Andrea Mastrángelo, Elena Bruzzesi, and Raffaele Dell'Acqua. These collaborations have contributed to advancing understanding in infectious diseases and immunological responses.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.

    A Moretta;C Bottino;D Pende;G Tripodi

  • Interleukin-2 therapy in patients with HIV infection.

    D. Abrams;Y. Lévy;M. H. Losso;A. Babiker

  • A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.

    Alessandro Moretta;Giuseppe Tambussi;Cristina Bottino;Gino Tripodi

  • The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

    Giuseppe Pantaleo;James F. Demarest;Timothy Schacker;Mauro Vaccarezza

  • Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.

    Marco Ripa;Laura Galli;Andrea Poli;Chiara Oltolini

  • HIV-1 DNA predicts disease progression and post-treatment virological control

    James P Williams;Jacob Hurst;Jacob Hurst;Wolfgang Stöhr;Nicola Robinson;Nicola Robinson

  • Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study

    Y. Lévy;I. Sereti;G. Tambussi;J. P. Routy

  • Short-course antiretroviral therapy in primary HIV infection.

    S Fidler;K Porter;F Ewings

  • Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.

    Cristina Bottino;Giuseppe Tambussi;Silvano Ferrini;Ermanno Ciccone

  • Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.

    Álvaro H. Borges;Michael J. Silverberg;Deborah Wentworth;Andrew E. Grulich

  • Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

    G. Paolo Rizzardi;Alexandre Harari;Brunella Capiluppi;Giuseppe Tambussi

  • Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.

    Kehmia Titanji;Francesca Chiodi;Rino Bellocco;Danika Schepis

  • Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

    Jacob Hurst;Matthias Hoffmann;Matthew Pace;Matthew Pace;James P. Williams

  • Risk of cancers during interrupted antiretroviral therapy in the SMART study.

    Michael J Silverberg;Jacqueline Neuhaus;Mark Bower;Daniela Gey

  • Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.

    Serena Spudich;Magnus Gisslen;Lars Hagberg;Evelyn Lee

  • Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele

    Lucinda Furci;Gabriella Scarlatti;Samuele Burastero;Giuseppe Tambussi

  • Impact of Therapeutic Immunization on HIV-1 Viremia after Discontinuation of Antiretroviral Therapy Initiated during Acute Infection

    Sabine Kinloch-De Loes;Bruno Hoen;Don E. Smith;Brigitte Autran

  • CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro

    Lucia Lopalco;Claudia Barassi;Claudia Pastori;Renato Longhi

  • Primary HIV-1 Infection Sets the Stage for Important B Lymphocyte Dysfunctions

    Kehmia Titanji;Francesca Chiodi;Rino Bellocco;Danika Schepis

  • ANTIGEN RECOGNITION BY HUMAN T CELL RECEPTOR y-POSITIVE LYMPHOCYTES Specific Lysis of Allogeneic Mixed Lymphocyte Culture BriefDefinitiveReport

    Ermanno Ciccone;Oriane Viale;Cristina Bottino;Daniela Pende

Frequent Co-Authors

Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Guido Poli
Guido Poli Vita-Salute San Raffaele University
Ermanno Ciccone
Ermanno Ciccone University of Genoa
David A. Cooper
David A. Cooper University of New South Wales
Lucia Lopalco
Lucia Lopalco Vita-Salute San Raffaele University
Mauro S. Malnati
Mauro S. Malnati Vita-Salute San Raffaele University
Antonella Castagna
Antonella Castagna Vita-Salute San Raffaele University
Alessandro Moretta
Alessandro Moretta University of Genoa
Cristina Bottino
Cristina Bottino University of Genoa
Elisa Vicenzi
Elisa Vicenzi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with healthcare fields like nursing and advanced practice roles. For those interested in expanding their clinical expertise, exploring acnp programs can be a valuable step. These programs equip Family Nurse Practitioners (FNPs) with the skills necessary for acute care settings, broadening career options.

For individuals aiming to fast-track their nursing education, enrolling in a nurse practitioner accelerated program can significantly reduce the time it takes to become a qualified nurse practitioner. These programs are designed for those who already hold degrees in other fields and want to transition into nursing swiftly.

If you are coming from a non-nursing background but want to enter the nursing profession, considering online bsn programs for non nurses offers a flexible and accessible pathway. These programs cater specifically to career changers and provide essential nursing competencies.

Additionally, accelerated nursing programs are an excellent option for those seeking a quicker and more manageable entry into nursing education without compromising quality. These pathways help build a foundation that can integrate with immunology research and clinical practice.

Best Scientists Citing Giuseppe Tambussi

Trending Scientists